Co-repressing immunometabolic processes in atherosclerosis

Cardiovascular disease is the primary cause of mortality in the world, and tightly associated with the metabolic syndrome, which is a cluster of interconnected metabolic dysfunctions including insulin resistance, obesity, hypertension and dyslipidaemias.

Clinical value of soluble suppression of tumourigenicity 2 (sST2) in addition to NTproBNP measurements in a general cardiac outpatient population

Soluble ST2 measurements could be beneficial in patients with uncertain signs of heart failure and confounding factors for NTproBNP elevation.

Cocaine consumption and acute coronary syndromes: a cross sectional study from the Swiss registry AMIS Plus

Cocaine abuse increases the risk of mortality by a factor of 5 and the risk of major adverse cardiac and cardiovascular events by a factor of 4 as compared with a sex and age-matched population hospitalised after an acute coronary syndrome.

Productivity loss and indirect costs in the year following acute coronary events in Switzerland

This study showed that ACS patients lost on average 36% of their annual productive time. Caregivers lost an additional 5%.

ICD insertion in previously undiagnosed left brachiocephalic vein obstruction

A large anterior jugular venous collateral had formed as a result of longstanding obstruction.

Infective endocarditis: prevention and antibiotic prophylaxis

The Swiss societies of Infectious Diseases (SSI), Pediatric Cardiology and Cardiology and the Pediatric Infectious Disease Group of Switzerland present the current update in a joint initiative.

Prof. Dr. Willibald Maier (1956–2020)